We are live on ! Find out more
JPMIA

J.P. Marvel Investment Advisors Portfolio holdings

AUM $871M
1-Year Est. Return 64.45%
This Fund
S&P 500
This Quarter Est. Return
+5.84%
1 Year Est. Return
+64.45%
3 Year Est. Return
+183.15%
5 Year Est. Return
+262.44%
10 Year Est. Return
AUM
$293M
AUM Growth
+$10.6M
Cap. Flow
+$751K
Cap. Flow %
0.26%
Top 10 Hldgs %
33.18%
Holding
86
New
2
Increased
10
Reduced
28
Closed
2

Top Buys

Rank Stock Value
1
AKAM icon
Akamai
AKAM
+$5.11M
2
ZAYO
Zayo Group Holdings, Inc.
ZAYO
+$3.02M
3
AMZN icon
Amazon
AMZN
+$1.75M
4
BAC icon
Bank of America
BAC
+$1.13M
5
MS icon
Morgan Stanley
MS
+$1.04M

Sector Composition

Rank Sector Weight
1 Healthcare 21.45%
2 Financials 13.95%
3 Technology 12.55%
4 Communication Services 10.33%
5 Consumer Discretionary 10.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IJH icon
76
iShares Core S&P Mid-Cap ETF
IJH
$126B
$237K 0.08%
7,180
EFA icon
77
iShares MSCI EAFE ETF
EFA
$79.7B
$234K 0.08%
4,049
ACLS icon
78
Axcelis
ACLS
$4.21B
$153K 0.05%
10,500
TEAR
79
DELISTED
TearLab Corporation
TEAR
$91K 0.03%
17,542
ALKS icon
80
Alkermes
ALKS
$8.15B
-12,770
Closed -$601K
NVS icon
81
Novartis
NVS
$292B
-92,352
Closed -$6.53M

Similar funds

J.P. Marvel Investment Advisors's Q4 2016 Portfolio in Review

As of Q4 2016, J.P. Marvel Investment Advisors held 86 positions worth $293M, up 3.8% from $282M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Trading was light in Q4 2016: portfolio turnover was 4.7%. J.P. Marvel Investment Advisors opened 2 new positions and exited 2, leaving the 86-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 28% a quarter earlier, followed by Financials and Technology.

  • J.P. Marvel Investment Advisors's largest Q4 2016 buy was Akamai: 80,300 shares worth $5.35M.
  • J.P. Marvel Investment Advisors added most to Amazon in Q4 2016, an estimated $1.75M increase.
  • J.P. Marvel Investment Advisors's biggest Q4 2016 reduction was Bristol-Myers Squibb, cutting an estimated $2.67M.
  • J.P. Marvel Investment Advisors fully exited Novartis in Q4 2016, selling an estimated $6.53M.
  • J.P. Marvel Investment Advisors's ten largest holdings make up 33% of its $293M portfolio in Q4 2016.
  • J.P. Marvel Investment Advisors opened 2 new positions and closed 2 in Q4 2016.
  • J.P. Marvel Investment Advisors's portfolio value rose 3.8% quarter-over-quarter to $293M.

Based on J.P. Marvel Investment Advisors's 13F filing for Q4 2016, filed 23 Feb 2017.